» Articles » PMID: 38483755

Pharmacological Insights: Mitochondrial ROS Generation by FNC (Azvudine) in Dalton's Lymphoma Cells Revealed by Super Resolution Imaging

Abstract

Nucleoside analogs are a common form of chemotherapy that disrupts DNA replication and repair, leading to cell cycle arrest and apoptosis. Reactive oxygen species (ROS) production is a significant mechanism through which these drugs exert their anticancer effects. This study investigated a new nucleoside analog called FNC or Azvudine, and its impact on ROS production and cell viability in Dalton's lymphoma (DL) cells. The study found that FNC treatment resulted in a time- and dose-dependent increase in ROS levels in DL cells. After 15 and 30 min of treatment with 2 and 1 mg/ml of FNC, mitochondrial ROS production was observed in DL cells. Furthermore, prolonged exposure to FNC caused structural alterations and DNA damage in DL cells. The results suggest that FNC's ability to impair DL cell viability may be due to its induction of ROS production and indicate a need for further investigation.

Citing Articles

Erbium oxide nanoparticles induce potent cell death, genomic instability and ROS-mitochondrial dysfunction-mediated apoptosis in U937 lymphoma cells.

Mohamed H, Elberry Y, Magdy H, Ismail M, Michael M, Eltayeb N Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40072553 DOI: 10.1007/s00210-025-03962-x.


Development and validation of a nomogram to assess the occurrence of liver dysfunction in patients with COVID-19 pneumonia in the ICU.

Wang Z, Zhao L, Xie K BMC Infect Dis. 2025; 25(1):332.

PMID: 40065225 PMC: 11892215. DOI: 10.1186/s12879-025-10684-1.

References
1.
Abdulaal A, Patel A, Charani E, Denny S, Mughal N, Moore L . Prognostic Modeling of COVID-19 Using Artificial Intelligence in the United Kingdom: Model Development and Validation. J Med Internet Res. 2020; 22(8):e20259. PMC: 7451108. DOI: 10.2196/20259. View

2.
Kirtonia A, Sethi G, Garg M . The multifaceted role of reactive oxygen species in tumorigenesis. Cell Mol Life Sci. 2020; 77(22):4459-4483. PMC: 11105050. DOI: 10.1007/s00018-020-03536-5. View

3.
Arora S, Bhardwaj A, Singh S, Srivastava S, McClellan S, Nirodi C . An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4. J Biol Chem. 2013; 288(29):21197-21207. PMC: 3774385. DOI: 10.1074/jbc.M113.484576. View

4.
Chen W, Zou P, Zhao Z, Chen X, Fan X, Vinothkumar R . Synergistic antitumor activity of rapamycin and EF24 via increasing ROS for the treatment of gastric cancer. Redox Biol. 2016; 10:78-89. PMC: 5048112. DOI: 10.1016/j.redox.2016.09.006. View

5.
Zhao H, Wu S, Li H, Duan Q, Zhang Z, Shen Q . ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer. Mol Ther Oncolytics. 2019; 14:299-312. PMC: 6726755. DOI: 10.1016/j.omto.2019.07.005. View